Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 97

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 97
---
 $      |       — |    |     | $     |      — |     | $      |       — |     | $              | — |     | $            | — |     | $     |         |
| Eric Lang(4)                                                                                |     | 2024 |     | $      | 446,154 |    |     | $     |      — |     | $      | 230,318 |     | $              | — |     | $            | — |     | $     | 676,472 |
| Chief Medical Officer                                                                       |     | 2023 |     | $      | 166,767 |    |     | $     |      — |     | $      | 120,735 |     | $              | — |     | $            | — |     | $     | 287,502 |
| Christian Kopfli                                                                            |     | 2024 |     | $      |       — |    |     | $     |      — |     | $      |       — |     | $              | — |     | $            | — |     | $     |       — |
| Former Chief Executive Officer, Former Chief Strategy Officer, and Former Vice Chairman (5) |     | 2023 |     | $      |  11,280 | -6 |     | $     |      — |     | $      | 149,633 |     | $              | — |     | $            | — |     | $     | 160,913 |

| (1) | Mr. Plesha was appointed to the position of Chief Executive Officer of Pelthos on July 1, 2025 following the consummation of the Merger between Channel and LNHC. |

| (2) | Mr. Knuettel resigned as Chief Executive Officer on July 1, 2025 with the consummation of the Merger between Channel and LNHC and was appointed to the position of Chief Financial Officer of Pelthos on July 1, 2025. |

| (3) | Mr. Rangarao was appointed to the position of Chief Commercial Officer of Pelthos on July 2, 2025 following the consummation of the Merger between Channel and LNHC. |

| (4) | Represents the portion of Dr. Lang’s salary attributable to his services to the Company during the year ended December 31, 2023. Dr.